World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7011)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

345

WORD

115

HTML

2424

Figures (1-6)

609

Tables (1-4)

528

Sum=4021

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

318

Download

1123

Sum=1441

Publishing Process of This Article

Item

Count

Browse

465

Download

1084

Sum=1549

May 24, 2022 (publication date) through Oct 25, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Sempokuya T, Forlemu A, Azawi M, Silangcruz K, Khoury N, Ma J, Wong LL. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World J Clin Oncol 2022; 13(5): 352-365 [PMID: 35662983 DOI: 10.5306/wjco.v13.i5.352]
URL:	https://www.wjgnet.com/2218-4333/full/v13/i5/352.htm

Number	Citing Articles
1	Leonardo Gomes da Fonseca, Raphael L C Araujo. Fibrolamellar hepatocellular carcinoma: Advances, challenges and opportunities in a rare malignancy. World Journal of Gastrointestinal Surgery 2025; 17(10): 109107 doi: 10.4240/wjgs.v17.i10.109107 Abstract(4) \| Core Tip(1) \| Full Article(HTML)(14) \| Full Article with Cover (PDF)-784K(2) \| Audio-951K(4) \| Peer-Review Report-233K(3) \| Answering Reviewers-255K(3) \| Full Article (PDF)-475K(4) \| Full Article (XML)-153K(2) \| Times Cited (0) \| Total Visits (127) \| Open
2	Travis Zack, Kurt P. Losert, Samantha M. Maisel, Jennifer Wild, Amin Yaqubie, Michael Herman, Jennifer J. Knox, Robert J. Mayer, Alan P. Venook, Atul Butte, Allison F. O’Neill, Ghassan K. Abou-Alfa, John D. Gordan. Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data. npj Precision Oncology 2023; 7(1) doi: 10.1038/s41698-023-00371-2
3	Bengi Öztürk. Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas. Cureus 2023; doi: 10.7759/cureus.50795
4	S. K. Daniel, K. M. Sullivan, L. K. Dickerson, R. J. E. van den Bijgaart, A. F. Utria, K. P. Labadie, H. L. Kenerson, X. Jiang, K. S. Smythe, J. S. Campbell, R. H. Pierce, T. S. Kim, K. J. Riehle, R. S. Yeung, J. A. Carter, K. C. Barry, V. G. Pillarisetty. Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55593-6
5	Hassan Aziz, Zachary J Brown, Seyedeh Panid Madani, Ihab R Kamel, Timothy M Pawlik. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management. Journal of the American College of Surgeons 2023; 236(2): 399 doi: 10.1097/XCS.0000000000000476